Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
3(33%)
Results Posted
80%(4 trials)

Phase Distribution

Ph not_applicable
2
22%
Ph phase_1
1
11%
Ph phase_4
2
22%
Ph phase_2
4
44%

Phase Distribution

1

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
4(44.4%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(5)
Other(1)

Detailed Status

Completed5
Recruiting2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 24 (44.4%)
Phase 42 (22.2%)
N/A2 (22.2%)

Trials by Status

active_not_recruiting111%
recruiting222%
unknown111%
completed556%

Recent Activity

3 active trials
Showing 5 of 9
completednot_applicable

Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans

NCT03039023
recruitingphase_2

Choline and Iron Deficiency

NCT06527391
active_not_recruitingphase_2

Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study

NCT05108974
recruitingphase_2

RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure

NCT04395196
completedphase_4

Effects of a Nutraceutic Compound on Cognitive Impairment

NCT06200883
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT03039023Not Applicable

Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans

Completed
NCT06527391Phase 2

Choline and Iron Deficiency

Recruiting
NCT05108974Phase 2

Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study

Active Not Recruiting
NCT04395196Phase 2

RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure

Recruiting
NCT06200883Phase 4

Effects of a Nutraceutic Compound on Cognitive Impairment

Completed
NCT02735473Phase 2

Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders

Completed
NCT04012177Not Applicable

Nutritional Support and Prophylaxis Doses of Azithromycin for Pregnant Women - Mumta Pregnant Women Trial

Unknown
NCT01149538Phase 1

Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure

Completed
NCT01749982Phase 4

A Preliminary Study of Choline and Betaine Supplementation Among Adults Exposed to Arsenic in Bangladesh

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9